ENDRA Life Sciences Inc. (NDRA)
undefined
undefined%
At close: undefined
4.27
0.71%
After-hours Dec 13, 2024, 04:42 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Revenue - - - - - 6.17K 351.62K 515.58K 1.41M 559.36K
Cost of Revenue 275.45K 234.26K 224.41K 165.25K 115.01K - 172.78K 235.88K 666.23K 259.14K
Gross Profit -275.45K -234.26K -224.41K -165.25K -115.01K 6.17K 178.84K 279.70K 743.83K 300.21K
Operating Income -10.52M -13.16M -11.50M -11.50M -10.84M -9.02M -4.63M -1.79M -1.57M -1.53M
Interest Income - - - 232.43 2.36K - - - - -
Pretax Income -10.06M -13.18M -11.23M -11.73M -13.31M -9.80M -5.38M -2.78M -2.28M -2.18M
Net Income -10.06M -13.20M -11.19M -11.97M -15.55M -9.80M -5.38M -2.78M -2.28M -2.18M
Selling & General & Admin 5.52M 6.60M 6.02M 5.58M 4.27M 4.02M 2.87M 1.58M 1.27M 953.22K
Research & Development 5.00M 6.55M 5.48M 5.92M 6.57M 4.72M 1.93M 495.38K 1.04M 873.17K
Other Expenses - -21.53K -41.55K 8.84K -106.90K -777.25K - -5.82K -711.34K -
Operating Expenses 10.52M 13.16M 11.50M 11.50M 10.84M 8.74M 4.80M 2.07M 2.31M 1.83M
Interest Expense - 21.53K - 232.43K 2.36M - - - - -
Selling & Marketing Expenses 820.55K 1.43M 1.08M 581.89K 412.43K 262.64K 122.60K 34.13K 50.63K 56.30K
Cost & Expenses 10.52M 13.16M 11.50M 11.50M 10.84M 8.74M 4.98M 2.31M 2.98M 2.09M
Income Tax - 21.53K -41.55K 241.27K 2.25M -777.25K 750.90K 983.61K 710.63K 654.70K
Shares Outstanding (Basic) 9.04M 2.89M 2.05M 959.61K 375.00K 225.24K 137.85K 195.35K 195.35K 195.35K
Shares Outstanding (Diluted) 9.04M 2.89M 2.05M 959.61K 375.00K 225.24K 195.75K 195.35K 195.35K 30.63K
EPS (Basic) -1.11 -4.57 -5.47 -12.47 -41.48 -43.49 -39.01 -14.21 -11.67 -11.16
EPS (Diluted) -1.11 -4.57 -5.47 -12.47 -41.48 -43.49 -39.01 -14.21 -11.67 -11.16
EBITDA -9.78M -12.94M -11.01M -11.33M -10.84M -9.02M -4.56M -1.73M -1.50M -1.49M
Depreciation & Amortization 275.45K 234.26K 224.41K 165.25K 115.01K 68.32K 61.48K 64.94K 72.22K 37.24K